The Dow Jones (NYSE:DIA) is lower 38 points at 12,112, the S&P 500 (NYSE:SPY) is down 9 points at 1,290 and the Nasdaq (NASDAQ:QQQ) lower 19 points to 2,713 on the 107th trading day of 2011, as these stocks hit our radar:
1) Bank of America (NYSE:BAC): Shares of BAC are lower 3.59% to $10.88 per share. The banking giant hit a 52-week low today. Over 135 million shares have traded hands. The fear on Wall Street is the bank will have to cover additional costs on mortgages following a bad jobs report on Friday. Bank of America Corporation accepts deposits and offers banking, investing, asset management, and other financial and risk-management products and services. The Company has a mortgage lending subsidiary, and an investment banking and securities brokerage subsidiary. Competitors to Watch: Citigroup (NYSE:C), Deutsche Bank (NYSE:DB), JPMorgan Chase (NYSE:JPM), HSBC (NYSE:HBC), Metlife (NYSE:MET), PNC (NYSE:PNC), U.S. Bancorp (NYSE:USB), Financials (NYSE:XLF) and Wells Fargo & Company (NYSE:WFC).
2) Microsoft (NASDAQ:MSFT): Shares are higher 1% to $24.14 per share. Over 30 million shares have traded hands. After 3 days of the stock declining, buyers are back buying value today. Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices. Competitors to Watch: Google Inc. (NASDAQ:GOOG), Novell, Inc. (NASDAQ:NOVL), Oracle Corporation (NASDAQ:ORCL), Intl. Business Machines Corp. (NYSE:IBM), Hewlett-Packard Company (NYSE:HPQ), Yahoo! Inc. (NASDAQ:YHOO), Apple Inc. (NASDAQ:AAPL), Adobe Systems Incorporated (NASDAQ:ADBE), Intel Corporation (NASDAQ:INTC), and Sony Corporation (NYSE:SNE).
3) Harley-Davidson (NYSE:HOG): Shares are up 3.57% to $37.16 per share today. Over 3.5 million shares have traded hands. UBS (NYSE:UBS) issued a short-term buy on the company’s shares. Weather is warmer, gas prices are hindering auto drivers and motorcycles a hot item for the Summer once again. Harley-Davidson, Inc. designs, manufactures, and sells motorcycles. The Company’s products include heavyweight touring, custom, and performance motorcycles, as well as a line of motorcycle parts, accessories, and general merchandise. Harley-Davidson also provides motorcycle floor planning and parts and accessories financing to its North American and European dealers. Competitors and companies in their category include Polaris Industries (NYSE:PII), Brunswick (NYSE:BC), Home Depot (NYSE:HD), Caterpillar (NYSE:CAT), General Motors (NYSE:GM), Ford (NYSE:F), Toyota (NYSE:TM) and Honda (NYSE:HMC).
4) SunOpta, Inc. (NASDAQ:STKL): Shares of SunOpta, Inc. are trading higher 3.24% to $7.64 per share today. 3 million shares have traded hands. SunOpta Inc. owns and operates businesses in the natural and organic food markets. The Company sources, processes, and distributes natural and organic food products. SunOpta also produces, distributes, and recycles environmentally friendly industrial materials. In addition, the Company engineers and markets clean pulping systems. Here’s how you can play the hot Commodities markets>>
5) Credicorp Ltd. (NYSE:BAP): Shares of Credicorp Ltd. are trading lower 15% to $86.05 per share today. Credicorp Limited is a holding company for Banco de Credito del Peru, El Pacifico-Peruano Suiza Insurance Company and Atlantic Security Holding Corporation, among others. Credicorp provides a full range of financial services including commercial banking, corporate finance, brokerage services, asset management, trust and insurance.
6) United Therapeutics Corporation (NASDAQ:UTHR): Shares of United Therapeutics Corporation are trading lower 5.5% to $59.24 per share today. Over 4 million shares have traded hands. United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company’s lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United’s products are currently in Phase III clinical trials.